TMS vs. Ketamine for Depression: How to Choose

· Updated November 2026 · Aazaz Haq, MD

DepressionEsketamineInsuranceInterventional PsychiatryKetamineMental WellnessOCDTMS

For people whose depression has not improved with medications, TMS and ketamine are two of the most common next steps. Both can help. They work differently and suit different situations. Here is how I help people choose.

The short answer

Ketamine works faster, often within days, but needs monitoring after each treatment and is usually self-pay unless it is Spravato. TMS takes a few weeks, has mild side effects, lets you drive yourself, and is covered by most insurance. Both help a meaningful share of people with treatment-resistant depression.

How each works

TMS is a non-invasive, FDA-cleared treatment that uses magnetic pulses from a coil on the scalp to stimulate mood circuits. Repeated sessions gradually strengthen how those circuits communicate.

Ketamine acts on glutamate, the brain's main "go" signal, and appears to help nerve cells rebuild connections quickly. At McLean NTC, we offer ketamine by IV infusion or intramuscular (IM) injection, and Spravato, the FDA-approved esketamine nasal spray.

Speed

Ketamine is faster. Many people who respond notice a change within hours to days. TMS usually takes a few weeks, and many people notice improvement in weeks three to six. If someone needs relief quickly, that difference counts.

Effectiveness

Both help a meaningful share of people with treatment-resistant depression, and neither helps everyone. In everyday clinics, about 6 in 10 people respond to a course of TMS. In ketamine trials, about half to two thirds of people improve within a day of an infusion, but the benefit fades without repeated treatment. There are no large trials directly comparing the two.

Side effects and daily life

  • TMS: headache or scalp discomfort early on; no sedation; you drive yourself home. Seizure is rare, about 1 in 30,000 sessions.
  • Ketamine: dissociation, nausea, sleepiness and a temporary rise in blood pressure on treatment day. You need monitoring afterward and cannot drive that day.

Schedule

TMS is daily on weekdays for about six weeks, then a taper, with sessions of about 19 minutes or about 3 minutes for theta burst. Ketamine and Spravato usually start twice a week for four weeks, then space out, and each visit takes one to two and a half hours including monitoring.

Cost and insurance

Because TMS is FDA-cleared for depression, it is widely covered by insurance, including Medicare. TMS for OCD is covered by some plans; for other conditions, treatment may need to be paid for out of pocket. Spravato is usually covered. Ketamine by IV or IM is typically self-pay. At McLean NTC it is $400 per treatment, and we offer payment plans.

Choosing

I lean toward ketamine or Spravato when speed is important, and toward TMS when someone wants no sedation, cannot arrange rides, or prefers a treatment that does not involve a medicine. Many people try one and later the other. Our side-by-side comparison lays this out visually.

To talk through which fits you, request a consultation call.

Questions I hear often

Can I do both at the same time?

Sometimes, but we usually start one at a time so we can tell what is helping. If someone responds partly to one, adding or switching to the other is a reasonable next step.

Which one is better for suicidal thoughts?

Esketamine is FDA-approved for depression with acute suicidal thoughts, and ketamine can reduce suicidal thinking within a day in studies. If someone is in immediate danger, though, the first step is emergency care: call or text 988, call 911, or go to the nearest emergency department.

What about people with a history of substance use?

TMS involves no medicine, so it is often the simpler choice. Ketamine is not automatically ruled out, but it needs careful evaluation and a clear plan.

A practical way to decide

If you need relief quickly and can arrange rides, ketamine or Spravato may make sense first. If you want to keep driving, prefer no medicine, or have blood pressure or substance use concerns, TMS may be the better starting point. Cost and coverage often tip the balance. Neither choice is permanent. Many people end up using both at different points, and a good plan includes what to do if the first choice does not work well enough.

References

  1. Carpenter LL, et al. TMS for major depression: a multisite, naturalistic, observational study. Depress Anxiety. 2012. PubMed
  2. Murrough JW, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression. Am J Psychiatry. 2013. PubMed
  3. Rossi S, et al. Safety and recommendations for TMS use. Clin Neurophysiol. 2021. PubMed

Ready to take the next step?

Nothing here commits you to treatment. Start with a free consultation call with our patient advocate, who calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean
Call (571) 378-1398Request a consultation call